Literature DB >> 34978648

Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators.

Menghan Niu1, Xin Yang2,3, Yuanyuan Li1, Yanping Sun1,4,5, Long Wang6, Jing Ha1, Yinghua Xie1, Zibin Gao1,4,5, Changzheng Tian7, Le Wang8,9, Yongjun Sun10,11,12.   

Abstract

NMDA receptors play an important physiological role in regulating synaptic plasticity, learning and memory. GluN2A subunits are the most abundant functional subunits of NMDA receptors expressed in mature brain, and their dysfunction is related to various neurological diseases. According to subunit composition, GluN2A-containing NMDA receptors can be divided into two types: diheteromeric and triheteromeric receptors. In this review, the expression, functional and pharmacological properties of different kinds of GluN2A-containing NMDA receptors as well as selective GluN2A regulators were described to further understand this type of NMDA receptors.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Expression; Function properties GluN2A-selective regulators; GluN2A-containing NMDA receptors

Year:  2022        PMID: 34978648     DOI: 10.1007/s10571-021-01185-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  122 in total

1.  Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits.

Authors:  Rana A Al-Hallaq; Bryan R Jarabek; Zhanyan Fu; Stefano Vicini; Barry B Wolfe; Robert P Yasuda
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

2.  NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus.

Authors:  Rana A Al-Hallaq; Thomas P Conrads; Timothy D Veenstra; Robert J Wenthold
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 3.  The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.

Authors:  Meysam Amidfar; Marie Woelfer; Gislaine Z Réus; João Quevedo; Martin Walter; Yong-Ku Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-06-14       Impact factor: 5.067

Review 4.  Excitatory and inhibitory amino acid neurotransmitters in stroke: from neurotoxicity to ischemic tolerance.

Authors:  Diana Amantea; Giacinto Bagetta
Journal:  Curr Opin Pharmacol       Date:  2017-08-17       Impact factor: 5.547

5.  Kinesin Kif3b mutation reduces NMDAR subunit NR2A trafficking and causes schizophrenia-like phenotypes in mice.

Authors:  Ashwaq Hassan Alsabban; Momo Morikawa; Yosuke Tanaka; Yosuke Takei; Nobutaka Hirokawa
Journal:  EMBO J       Date:  2019-11-20       Impact factor: 11.598

6.  Ifenprodil effects on GluN2B-containing glutamate receptors.

Authors:  Stacy A Amico-Ruvio; Meaghan A Paganelli; Jason M Myers; Gabriela K Popescu
Journal:  Mol Pharmacol       Date:  2012-08-30       Impact factor: 4.436

7.  Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice.

Authors:  Ariadna Amador; Christopher D Bostick; Heather Olson; Jurrian Peters; Chad R Camp; Daniel Krizay; Wenjuan Chen; Wei Han; Weiting Tang; Ayla Kanber; Sukhan Kim; JiaJie Teoh; Megha Sah; Sabrina Petri; Hunki Paek; Ana Kim; Cathleen M Lutz; Mu Yang; Scott J Myers; Subhrajit Bhattacharya; Hongjie Yuan; David B Goldstein; Annapurna Poduri; Michael J Boland; Stephen F Traynelis; Wayne N Frankel
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

8.  Differential role of N-methyl-D-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits.

Authors:  N C Anastasio; Y Xia; Z R O'Connor; K M Johnson
Journal:  Neuroscience       Date:  2009-08-03       Impact factor: 3.590

9.  Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency - molecular profiling and functional rescue.

Authors:  L Addis; J K Virdee; L R Vidler; D A Collier; D K Pal; D Ursu
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

Review 10.  The Ketamine Antidepressant Story: New Insights.

Authors:  Tahani K Alshammari
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.